2Ballard C, Mckeith IG, Ayre GA. et al. Impairmentsin attention and fluctuating attention distinguish between dementia with lewy bodies and Alzheimer's disease. Neurology, 2000,54( S3 ) :A451.
3Walker MP, Ayre GA, Perry EK, et al. Quantification and characterization of fluctuating cognition in dementia with lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord, 2000,11 (6) :327.
4Gnanalingham KK, Byrne E J, Thornton A, et al. Motor and cognitive function in lewy body dementia: comparison with Alzhemer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry, 1997,62(3 ) :243.
5Ceravolo R, Volterrani D, Gambaccini G, et al. Dopaminergic degeneration and perfusional impairment in lewy body dementia and Alzheimer's disease. Neurol Sci,2003,24 ( 3 ): 162.
6Ballard C, Holmes C, McKeith I, et al. Psychiatric morbidity in dementia with lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry,1999,156(7) :1 039.
7McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with lewy body (DLB): report of the consortium on DLB international workshop.Neurology, 1996,47 ( 5 ): 1 113.
8Swanberg MM, Cummings JL. Benefit-risk considerations in the treatment of dementia with lewy bodies. Drug Saf, 2002,25(7) :511.
9Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadri- paresis in flexion[J]. J Neuropath Exp Neurol, 1961,20(2) :237- 244.
10McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium[J]. Neu- rology, 2005,65 ( 12 ) : 1863 - 1872.
